1. health and fitness

Vulvar Cancer Market Share, Symptoms, Treatment, Causes,
Overview and Pipeline Review, H1 2016
Summary
Global Markets Direct's, 'Vulvar Cancer - Pipeline Review, H1 2016', provides an overview of the Vulvar Cancer
pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Vulvar Cancer,
complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration
(RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its
complete research and development history and latest news and press releases. Additionally, the report provides
an overview of key players involved in therapeutic development for Vulvar Cancer and features dormant and
discontinued projects.
To Get Full Report Click Here @ http://www.radiantinsights.com/research/vulvar-cancer-pipeline-review-h12016
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and
nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's
proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university sites and industry-specific third party sources.
Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that
all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes
ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision
making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
Scope
- The report provides a snapshot of the global therapeutic landscape of Vulvar Cancer
- The report reviews pipeline therapeutics for Vulvar Cancer by companies and universities/research institutes
based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till
discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description,
descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Vulvar Cancer therapeutics and enlists all their major and minor projects
- The report assesses Vulvar Cancer therapeutics based on drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Vulvar Cancer
Reasons To Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain
competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Vulvar Cancer
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Vulvar Cancer pipeline depth and focus of
Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most
attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove
them from pipeline
Buy a Sample Copy of This Report @ http://www.radiantinsights.com/research/vulvar-cancer-pipeline-reviewh1-2016/request-sample
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Vulvar Cancer Overview 6
Therapeutics Development 7
Pipeline Products for Vulvar Cancer - Overview 7
Pipeline Products for Vulvar Cancer - Comparative Analysis 8
Vulvar Cancer - Therapeutics under Development by Companies 9
Vulvar Cancer - Therapeutics under Investigation by Universities/Institutes 10
Vulvar Cancer - Pipeline Products Glance 11
Clinical Stage Products 11
Vulvar Cancer - Products under Development by Companies 12
Vulvar Cancer - Products under Investigation by Universities/Institutes 13
Vulvar Cancer - Companies Involved in Therapeutics Development 14
ISA Pharmaceuticals B.V. 14
Ono Pharmaceutical Co., Ltd. 15
Oryx GmbH & Co. KG 16
PDS Biotechnology Corporation 17
Vulvar Cancer - Therapeutics Assessment 18
Assessment by Monotherapy Products 18
Assessment by Target 19
Assessment by Mechanism of Action 21
Assessment by Route of Administration 23
Assessment by Molecule Type 25
Drug Profiles 27
Cellular Immunotherapy for HPV Associated Cancers - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
ISA-101 - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
nivolumab - Drug Profile 30
To Get Full Report Click Here @ http://www.radiantinsights.com/research/vulvar-cancer-pipeline-review-h12016
About Us:
Radiant Insights Inc. is a platform for companies looking to meet their market research and business intelligence
requirements. We assist and facilitate organizations and individuals procure market research reports, helping them
in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries
and a host of micro markets. In addition to over extensive database of reports, our experienced research
coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research
solutions.
Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
28 2nd Street,
Suite 3036 San Francisco,
CA 94105 United States
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Website: http://www.radiantinsights.com/
Email: [email protected]
Visit our Blog: http://chemicalsandmaterialsri.blogspot.com